Viewing Study NCT01873261


Ignite Creation Date: 2025-12-17 @ 1:44 PM
Ignite Modification Date: 2025-12-23 @ 4:54 PM
Study NCT ID: NCT01873261
Status: UNKNOWN
Last Update Posted: 2013-06-10
First Post: 2013-02-19
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: NIV NAVA Versus NIV-PS in Pediatric Patients - Pilot Study
Sponsor: Hospital Universitario La Paz
Organization:

Study Overview

Official Title: Neurally Adjusted Ventilatory Assist (NAVA) Versus Pressure Support in Pediatric Acute Respiratory Failure - Pilot Study
Status: UNKNOWN
Status Verified Date: 2013-06
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: NINAVAPed
Brief Summary: This pilot study will be an observational no randomize study in which the NiNAVAped protocol will be applied solely to the NIV NAVA arm.
Detailed Description: This pilot study will be an observational no randomize study in which the NiNAVAped protocol will be applied solely to the NIV NAVA arm.

Every PICU will have to include 3 patients in the Pilot study before starting the clinical trial, which means that the pilot study will involve a maximum of 60 patients.

Should the Pilot study reveal deficiencies in the NiNAVAped design, the protocol would be improved accordingly.

There will be a specific consent document during the Pilot study. The Pilot study will be published in a scientific journal.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: